In men, inversely, the SLC19A1 c.80AA genotype was associated with a protection against lung cancer as compared to the GG genotype (OR = 0.39, 95% CI: 0.17–0.91, P = 0.03), but this association was no longer significant after correction for multiple comparisons. Here, SLC19A1 is linked to lung cancer.